Mary Mulready Sullivan Oncology Symposium (2023): Innovations in Cancer Care: Precision in Diagnostics and Treatment

Add to Calendar Mary Mulready Sullivan Oncology Symposium (2023): Innovations in Cancer Care: Precision in Diagnostics and Treatment 5/25/2023 8:00:00 AM 5/25/2023 1:30:00 PM America/New_York For More Details: https://hhchealth.cloud-cme.com/MMS_2023 Description: In Person Registration Closes 5/23/23 @ 11:59pmVirtual Registration Closes 5/24/23 @ 12pmThe goal of precision medicine is simply to deliver the right cancer treatment to the right patient at the right dose and the right time. This enhances the likelihood of response and hopefully lowers the risk of toxicity, thereby enhancing the therapeutic ratio. While many of us think of cancer genomics determined by next generatio... Zoom & In Person (Contact [email protected] for information)) false MM/DD/YYYY


Thursday, May 25, 2023, 8:00 AM - 1:30 PM EST, Hartford HealthCare Cancer Instititute, Zoom & In Person (Contact [email protected] for information)), Hartford, CT


In Person Registration Closes 5/23/23 @ 11:59pm

Virtual Registration Closes 5/24/23 @ 12pm

The goal of precision medicine is simply to deliver the right cancer treatment to the right patient at the right dose and the right time. This enhances the likelihood of response and hopefully lowers the risk of toxicity, thereby enhancing the therapeutic ratio. While many of us think of cancer genomics determined by next generation sequencing as the center of precision oncology, whereby an alteration in a particular cancer gene can predict a response to a targeted therapy, many other targeted approaches also comprise precision characteristics. Included in this ever-changing landscape are many biomarkers and targeted therapeutic approaches which when utilized by a patient’s team can result in a highly personalized treatment plan.


Objectives
As a result of participating in this activity, learners should be able to:

  1. Review the biology of cell free DNA and its potential for screening for cancer through a simple blood test.
  2. Articulate how a targeted molecule can advance both diagnostic imaging and therapeutic radioactive treatment of select tumors in theranostics.
  3. Assess treatment of selected hematologic and solid tumors using T immune cells modified and expanded in CAR T cell terapy.
  4. Explain advantages of innovative robotic surgical approaches and stereotactic and proton therapies in maximizing cancer eradication and minimizing normal tissue injury.


AMA PRA Category 1 Credits™ (4.50 hours), ABIM MOC Part 2 (4.50 hours), ABS CC (4.50 hours), ABS CC SAM (4.50 hours), ANCC Contact Hour(s) (4.50 hours), Non-Physician Attendance (credits designated as AMA PRA Category 1) (4.50 hours), Oncology Education (4.50 hours)


Specialties - Internal Medicine, Nursing, Oncology and Hematology, Pharmacology, Clinical, Radiation Oncology, Surgery (All)
Professions - All Professions


In support of improving patient care, Hartford HealthCare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Hartford HealthCare designates this activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Nurses: This activity is designated for a maximum of 4.50 ANCC contact hours.

Other Learners: All other learners will receive a Certificate of Participation.  Consult your professional licensing board regarding the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by Joint Accreditation for Interprofessional Continuing Education.



Accessibility Statement
 
Hartford HealthCare is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact [email protected].